Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Short-term Investments: 2020-2025

Historic Short-term Investments for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $93.5 million.

  • Mirum Pharmaceuticals' Short-term Investments rose 52.14% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.5 million, marking a year-over-year increase of 52.14%. This contributed to the annual value of $57.8 million for FY2024, which is N/A change from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Short-term Investments stood at $93.5 million for Q3 2025, which was up 22.37% from $76.4 million recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Short-term Investments peaked at $149.6 million during Q3 2022, and registered a low of $3.0 million during Q3 2023.
  • In the last 3 years, Mirum Pharmaceuticals' Short-term Investments had a median value of $61.5 million in 2024 and averaged $57.6 million.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Short-term Investments slumped by 98.01% in 2023 and then surged by 1,969.20% in 2024.
  • Mirum Pharmaceuticals' Short-term Investments (Quarterly) stood at $125.2 million in 2021, then fell by 1.19% to $123.7 million in 2022, then plummeted by 98.01% to $3.0 million in 2023, then soared by 1,969.20% to $57.8 million in 2024, then surged by 52.14% to $93.5 million in 2025.
  • Its Short-term Investments was $93.5 million in Q3 2025, compared to $76.4 million in Q2 2025 and $65.9 million in Q1 2025.